ZLDPF · Zealand Pharma A/S/ADR
Market Cap
$3.22B
Shares
67.66M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$46.38
Open$46.61
Day$46.04–46.77
52W close$38.95–83.12
Avg vol 30d968
Short int533K · 0.8% float · 999+d
Short vol34%
Last earningsAug 13, 2026
DataJan 2020–Sep 2026
Up next
Next earnings call
Nov 9, 2026
Est · unconfirmed
· in 9 wks
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-33.4%
Trailing year
Short interest
0.8%
Latest settlement · 999+ days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.7 · calm
Equity put/call 0.48
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−23%
below
Price vs 50-day avg
−2%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
17%
mid-range
Momentum
relative strength
1-month return
+3%
trailing
6-month return
−38%
trailing
YTD return
−35%
this year
Relative strength
−52%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $47 › 200d $61 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.79% of float · ▼ -6.5% MoM · 1000.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
No 13F holder history
Squeeze score
61
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
89%
annualized · 1-yr
Max drawdown
−64%
past year
ATR
3.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−23%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
17%
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $47 › 200d $61 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.79% of float · ▼ -6.5% MoM · 1000.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $39
Now $46 · 17%
Range high $83
vs 200-day avg -23%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ZLDPF
this stock
Zealand Pharma A/S/ADR
|
$3.22B | -35.2% | — | — | 0.8% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.42B | +16.7% | +46.2% | 31.8 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.22B | +5.0% | +20.8% | 20.5 | 2.3% |
|
ARGX
Argenx SE
|
$62.63B | +19.8% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$60.54B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ZLDPF | -10.5% | +3.4% | -38.2% | -0.5% | -35.2% |
| SPY | -0.1% | -0.9% | +14.2% | -0.1% | +12.3% |
| vs SPY | -10.3% | +4.3% | -52.4% | -0.3% | -47.6% |